The evidence base for transdermal B12 absorption is weak, well-conducted oral and sublingual studies show dramatically better absorption, and the patches cost more per effective dose
By mid-2026 it has an established label, a defined titration schedule, and years of post-approval use behind it
This meets the needs of various patients and clinical situations
Usually after 3 months we should recheck its levels, in order to have a better estimate
The recent buzz surrounding the FDA's decision on BPC 157, a peptide renowned for its potential healing properties, has created quite a stir
It is classified as a modified peptide fragment and is supplied as a white to off-white lyophilized (freeze-dried) powder that is readily soluble in water